TY - JOUR
T1 - The relationship between interleukin-6 levels and physical performance in mobility-limited older adults with chronic low-grade inflammation
T2 - The ENRGISE Pilot study
AU - for the ENRGISE study investigators
AU - Custodero, Carlo
AU - Anton, Stephen D.
AU - Beavers, Daniel P.
AU - Mankowski, Robert T.
AU - Lee, Stephanie A.
AU - McDermott, Mary M.
AU - Fielding, Roger A.
AU - Newman, Anne B.
AU - Tracy, Russel P.
AU - Kritchevsky, Stephen B.
AU - Ambrosius, Walter T.
AU - Pahor, Marco
AU - Manini, Todd M.
N1 - Funding Information:
The ENRGISE Pilot Study is funded by National Institutes of Health (NIH) , National Institute on Aging (NIA) Cooperative Agreement U01 AG050499 and sponsored in part by the Intramural Research Program, NIA, NIH. The research is partially supported by the Claude D. Pepper Older Americans Independence Centers at the University of Florida ( 1 P30 AG028740 ), Wake Forest University ( 1 P30 AG21332 ), Tufts University ( 1P30AG031679 ), and University of Pittsburgh ( P30 AG024827 ). Dr. Roger Fielding (Tufts University) is partially supported by the U.S. Department of Agriculture under agreement 58–1950–0-014. The views of the authors do not reflect those of the Department of Agriculture. Abbott Laboratories provided funding for the purchase of the study drug and matching placebo.
Funding Information:
The ENRGISE Pilot Study is funded by National Institutes of Health (NIH), National Institute on Aging (NIA) Cooperative AgreementU01 AG050499 and sponsored in part by the Intramural Research Program, NIA, NIH. The research is partially supported by the Claude D. Pepper Older Americans Independence Centers at the University of Florida (1 P30 AG028740), Wake Forest University (1 P30 AG21332), Tufts University (1P30AG031679), and University of Pittsburgh (P30 AG024827). Dr. Roger Fielding (Tufts University) is partially supported by the U.S. Department of Agriculture under agreement 58?1950?0-014. The views of the authors do not reflect those of the Department of Agriculture. Abbott Laboratories provided funding for the purchase of the study drug and matching placebo.
Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Previous studies have found an inverse relation between serum concentrations of interleukin (IL)-6 and physical performance in seniors, however this was limited to higher functioning older adults with low to moderate levels of inflammation. We explored the consistency of this association in a cohort of mobility limited older adults with chronic low-grade inflammation. This study included 289 participants (≥ 70 years old) with IL-6 level between 2.5 and 30 pg/mL and a walking speed < 1.0 m/sec from the ENRGISE Pilot study. Physical performance was assessed using the short physical performance battery (SPPB), usual gait speed over 400 m, grip strength, and knee extensor and flexor strength measured by isokinetic dynamometry at 60 and 180°/sec. There was a significant inverse correlation between log IL-6 and knee extensor strength at 60°/sec (r= -0.20, p = 0.002), at 180°/sec (r = -0.14, p = 0.037), and knee flexor strength at 60°/sec (r = -0.15, p = 0.021). After adjustment for potential confounders, the values of knee extensor strength at 60°/sec showed a trend toward a progressive reduction across IL-6 tertiles as IL-6 levels increased (p = 0.024). No significant association was found between IL-6 and other objectively measured physical performance. The findings were generally of smaller magnitude and less consistent than previously reported, which suggests that the associations are attenuated in those with both elevated inflammation and mobility limitations. These results have implications for planning and interpreting future intervention studies in older adults with low-grade inflammation and mobility limitations.
AB - Previous studies have found an inverse relation between serum concentrations of interleukin (IL)-6 and physical performance in seniors, however this was limited to higher functioning older adults with low to moderate levels of inflammation. We explored the consistency of this association in a cohort of mobility limited older adults with chronic low-grade inflammation. This study included 289 participants (≥ 70 years old) with IL-6 level between 2.5 and 30 pg/mL and a walking speed < 1.0 m/sec from the ENRGISE Pilot study. Physical performance was assessed using the short physical performance battery (SPPB), usual gait speed over 400 m, grip strength, and knee extensor and flexor strength measured by isokinetic dynamometry at 60 and 180°/sec. There was a significant inverse correlation between log IL-6 and knee extensor strength at 60°/sec (r= -0.20, p = 0.002), at 180°/sec (r = -0.14, p = 0.037), and knee flexor strength at 60°/sec (r = -0.15, p = 0.021). After adjustment for potential confounders, the values of knee extensor strength at 60°/sec showed a trend toward a progressive reduction across IL-6 tertiles as IL-6 levels increased (p = 0.024). No significant association was found between IL-6 and other objectively measured physical performance. The findings were generally of smaller magnitude and less consistent than previously reported, which suggests that the associations are attenuated in those with both elevated inflammation and mobility limitations. These results have implications for planning and interpreting future intervention studies in older adults with low-grade inflammation and mobility limitations.
KW - Chronic low-grade inflammation
KW - Interleukin-6
KW - Knee muscle strength
KW - Physical performance
UR - http://www.scopus.com/inward/record.url?scp=85086389996&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086389996&partnerID=8YFLogxK
U2 - 10.1016/j.archger.2020.104131
DO - 10.1016/j.archger.2020.104131
M3 - Article
C2 - 32554219
AN - SCOPUS:85086389996
SN - 0167-4943
VL - 90
JO - Archives of Gerontology and Geriatrics
JF - Archives of Gerontology and Geriatrics
M1 - 104131
ER -